Clinical use of cyclosporine as an adjunctive therapy in the management of feline idiopathic pure red cell aplasia

Journal of Feline Medicine and Surgery

Volumn 13, Issue 12, 2011, Pages 885-895

  Viviano, Katrina R ^a   Webb, Julie L ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FELIDAE;

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADJUVANT CHEMOTHERAPY; ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; DRUG ADMINISTRATION; FEMALE; MALE; PURE RED CELL ANEMIA; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ANIMALS; CAT DISEASES; CATS; CHEMOTHERAPY, ADJUVANT; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MALE; RED-CELL APLASIA, PURE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84857925020     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2011.07.007     Document Type: Article

References (46)

1. Djaldetti M, Blay A, Bergman M, Salman H, Bessler H. Pure red cell aplasiaea rare disease with multiple causes. Biomed Pharmacother 2003; 57: 326-32.
2. Fisch P, Handgretinger R, Schaefer HE. Pure red cell aplasia. Br J Haematol 2000; 111: 1010-22.
3. Sawada K, Hirokawa M, Fujishima N. Diagnosis and management of acquired pure red cell aplasia. Hematol Oncol Clin North Am 2009; 23: 249-59.
4. Stokol T, Blue JT, French TW. Idiopathic pure red cell aplasia and nonregenerative immune-mediated anemia in dogs: 43 cases (1988-1999). J Am Vet Med Assoc 2000; 216: 1429-36.
5. Weiss DJ. Primary pure red cell aplasia in dogs: 13 cases (1996-2000). J Am Vet Med Assoc 2002; 221: 93-5.
6. Weiss DJ. Bone marrow pathology in dogs and cats with non-regenerative immune-mediated haemolytic anaemia and pure red cell aplasia. J Comp Pathol 2008; 138: 46-53.
7. Stokol T, Blue JT. Pure red cell aplasia in cats: 9 cases (1989-1997). J Am Vet Med Assoc 1999; 214: 75-9.
8. Clark DA, Dessypris EN, Krantz SB. Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood 1984; 63: 277-86.
9. Lacy MQ, Kurtin PJ, Tefferi A. Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood 1996; 87: 3000-6.
10. Mamiya S, Itoh T, Miura AB. Acquired pure red cell aplasia in Japan. Eur J Haematol 1997; 59: 199-205.
11. Marmont AM. Therapy of pure red cell aplasia. Semin Hematol 1991; 28: 285-97.
12. Raghavachar A. Pure red cell aplasia: review of treatment and proposal for a treatment strategy. Blut 1990; 61: 47-51.
13. Sawada K, Hirokawa M, Fujishima N. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA collaborative study group. Haematologica 2007; 92: 1021-8.
14. Williams DL, Mageed AS, Findley H, Ragab AH. Cyclosporine in the treatment of red cell aplasia. Am J Pediatr Hematol Oncol 1987; 9: 314-6.
15. Krantz SB. Pure red cell aplasia: biology and treatment. In: Feig SA, FM, eds. Clinical disorders and experimental models of erythropoietic failure. Florida: CRC Press, 1993: 86-127.
16. Sawada K, Fujishima N, Hirokawa M. Acquired pure red cell aplasia: updated review of treatment. Br J Haematol 2008; 142: 505-14.
17. Dean GA, Groshek PM, Mullins JI, Hoover EA. Hematopoietic target cells of anemogenic subgroup C versus nonanemogenic subgroup A feline leukemia virus. J Virol 1992; 66: 5561-8.
18. Hoover EA, Kociba GJ, Hardy Jr WD, Yohn DS. Erythroid hypoplasia in cats inoculated with feline leukemia virus. J Natl Cancer Inst 1974; 53: 1271-6.
19. Jarrett O, Golder MC, Toth S, Hay D. Interaction between feline leukaemia virus subgroups in the pathogenesis of erythroid hypoplasia. Int J Cancer 1984; 34: 283-8.
20. Mackey L, Jarrett W, Jarrett O, Laird H. Anemia associated with feline leukemia virus infection in cats. J Natl Cancer Inst 1975; 54: 209-17.
21. Onions D, Jarrett O, Testa N, Frassoni F, Toth S. Selective effect of feline leukaemia virus on early erythroid precursors. Nature 1982; 296: 156-8.
22. Weiss DJ. Antibody-mediated suppression of erythropoiesis in dogs with red blood cell aplasia. Am J Vet Res 1986; 47: 2646-8.
23. Mischke R. [Cyclosporine A therapy in a cat with pure red cell aplasia]. Berl Munch Tierarztl Wochenschr 1998; 111: 432-7.
24. Harvey JW. Canine bone marrow: normal hematopoiesis, biopsy techniques, and cell identification and evaluation. Compend Contin Educ Pract Vet 1984; 6: 909-26.
25. Dessypris ENL. Red cell aplasia. In: Greer JP, Lukens JN, Rogers GM, Paraskevas MD, Glader B, eds. Wintrobe's clinical hematology. 11th edn. Philadelphia: Lippincott Williams and Wilkins, 2004: 1421-7.
26. Kaplan E, Pisoni NJ, Stockham SL. Erythroid hypoplasia: recovery with immunosuppressive therapy. Vet Med 1985; 80: 22-9.
27. Nemoto Y, Tsutani H, Imamura S, Ishizaka T, Urasaki Y, Fukushima T, et al. Successful treatment of acquired myelofibrosis with pure red cell aplasia by cyclosporine. Br J Haematol 1999; 104: 422-4.
28. Weiss DJ. Uniform evaluation and semiquantitative reporting of hematologic data in veterinary laboratories. Vet Clin Pathol 1984; 13: 27-31.
29. Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P. Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N Engl J Med 1996; 334: 630-3.
30. Charles RJ, Sabo KM, Kidd PG, Abkowitz JL. The pathophysiology of pure red cell aplasia: implications for therapy. Blood 1996; 87: 4831-8.
31. Handgretinger R, Geiselhart A, Moris A, Grau R, Teuffel O, Bethge W, et al. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N Engl J Med 1999; 340: 278-84.
32. Gilmour MLM, Thrall MA. Investigating primary acquired pure red cell aplasia in dogs. Vet Med 1991; 86: 1199-204.
33. Dessypris EN. Pure red cell aplasia. In: Hoffman R, ed. Hematologic basic principles and practice. 3rd edn. New York: Churchill Livingstone, 2000: 342-54.
34. Dessypris EN. Pure red cell aplasia. London. Baltimore (MD): The Johns Hopkins University Press, 1988.
35. Tötterman TH, Höglund M, Bengtsson M, Simonsson B, Almqvist D, Killander A. Treatment of pure red-cell aplasia and aplastic anaemia with ciclosporin: longterm clinical effects. Eur J Haematol 1989; 42: 126-33.
36. Teramura M, Kimura A, Iwase S, Yonemura Y, Nakao S, Urabe A, et al. Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporine Awith or without G-CSF in adults: a multicenter randomized study in Japan. Blood 2007; 110: 1756-61.
37. Ho S, Clipstone N, Timmermann L, Northrop J, Graef I, Fiorentino D, et al. The mechanism of action of cyclosporine A and FK506. Clin Immunol Immunopathol 1996; 80: S40-5.
38. Vaden SL. Cyclosporine. In: Bonagura JD, ed. Current veterinary therapy XIII. Philadelphia: WB Saunders, 1995: 73-7.
39. Gregory C. Immunosuppressive agents. In: Bonagura J, ed. Kirk's current veterinary therapy: XIII small animal practice. Philadelphia: WB Saunders, 2000: 509-13.
40. Gregory CR, Madewell BR, Griffey SM, Torten M. Feline leukemia virus-associated lymphosarcoma following renal transplantation in a cat. Transplantation 1991; 52: 1097-9.
41. Schmiedt CW, Grimes JA, Holzman G, McAnulty JF. Incidence and risk factors for development of malignant neoplasia after feline renal transplantation and cyclosporine-based immunosuppression. Vet Comp Oncol 2009; 7: 45-53.
42. Ebo DG, Piel GC, Conraads V, Stevens WJ. IgE-mediated anaphylaxis after first intravenous infusion of cyclosporine. Ann Allergy Asthma Immunol 2001; 87: 243-5.
43. Kuiper RA, Malingré MM, Beijnen JH, Schellens JH. Cyclosporine-induced anaphylaxis. Ann Pharmacother 2000; 34: 858-61.
44. Liau-Chu M, Theis JG, Koren G. Mechanism of anaphylactoid reactions: improper preparation of high-dose intravenous cyclosporine leads to bolus infusion of Cremophor EL and cyclosporine. Ann Pharmacother 1997; 31: 1287-91.
45. Takamatsu Y, Ishizu M, Ichinose I, Ogata K, Onoue M, Kumagawa M, et al. Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient. Bone Marrow Transplant 2001; 28: 421-3.
46. Theis JG, Liau-Chu M, Chan HS, Doyle J, Greenberg ML, Koren G. Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL. J Clin Oncol 1995; 13: 2508-16.